WSJ Tech News Briefing TNB Tech Minute: Nasdaq-100 Will Allow Fast Entry for Large Companies Like SpaceX and OpenAI
26 snips
Mar 30, 2026 A rule change at Nasdaq that lets very large companies join the Nasdaq-100 much faster. A major pharma deal where Eli Lilly secures AI-derived drug rights and a multibillion-dollar potential payout. General Motors ramps up heavy-duty truck production to meet booming demand despite fuel and EV trends.
AI Snips
Chapters
Transcript
Episode notes
Nasdaq-100 Fast Track For Mega Startups
- Nasdaq will let some large, newly public companies join the NASDAQ-100 much faster starting May 1.
- The change responds to bankers pushing index providers so hot startups like OpenAI, Anthropic, and SpaceX can access index-driven capital sooner.
Why Index Inclusion Matters For Capital Access
- Traditional index waiting periods exist to prove a company's stability and sufficient trading volume for large buying and selling.
- Inclusion unlocks retail and institutional capital from funds that track the NASDAQ-100, materially increasing demand for a company's shares.
Eli Lilly Bets Big On AI Drug Discovery
- Eli Lilly will partner with Hong Kong-listed Insilico, paying $115 million upfront and up to roughly $2.75 billion plus royalties for AI-discovered drugs.
- Lilly gets exclusive worldwide rights to produce and sell oral treatments discovered with Insilico's AI across multiple therapeutic areas.